There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Arvinas Holding Company (ARVN – Research ...
Charles Schwab Investment Management Inc. lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 1.0% during the 4th quarter, according to its most recent disclosure with the ...
Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Arvinas in a report issued on Tuesday, March 18th. Cantor Fitzgerald analyst L. Watsek now forecasts that the ...
2025年3月19日, Arvinas(ARVN)披露1笔公司内部人交易情况。高管Berkowitz Noah于2025年3月18日卖出8658股。 2025年3月19日 高管 Berkowitz Noah 2025年3月18日 卖出 8658 8.59 7.44万 2025年2月25日 高管 Taylor Ian 2025年2月24日 卖出 1664 16.55 2.75万 2025年2月25日 ...
The phase 3 VERITAC-2 trial has been evaluating the candidate against AstraZeneca’s endocrine therapy Faslodex (fulvestrant) ...
We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...